Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

50.45
Delayed Data
As of Feb 08
 -0.94 / -1.83%
Today’s Change
37.59
Today|||52-Week Range
76.69
-6.70%
Year-to-Date

Today’s Trading

Previous close51.39
Today’s open50.81
Day’s range49.34 - 51.15
Volume4,949,561
Average volume (3 months)7,498,765
Market cap$25.3B
Dividend yield--
Data as of 02/08/2016

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+21.64%
Earnings growth (next 5 years)+7.80%
Revenue growth (last year)+11.45%
P/E ratio21.7
Price/Sales2.89
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-4.61-5.32%
PRGOPerrigo Company PLC-6.06-4.21%
ZTSZoetis Inc-0.72-1.76%
SHPGShire-6.92-4.40%
Data as of 02/08/2016

Financials

Next reporting dateFebruary 11, 2016
EPS forecast (this quarter)$1.28
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

Partner Offers